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Objective To achieve a fast and reliable determination of the susceptibility of Candida strains to amphotericin B
(Am B), fluconazole (Flu) and 5-fluorocytosine (5-FC), using cytometric methods as an alternative to the
classical dilution method.
Methods Twenty-three clinical isolates of Candida with different susceptibility patterns were treated for 1 h
with two concentrations each of Am B (2 and 8 mg/L), Flu (8 and 64 mg/L) and 5-FC (4 and 32 mg/L),
followed by staining with three different fluorochromes, under conditions previously defined through
an optimisation study. These were 1 mg/L propidium iodide (PI)/106 cells for 30 min at 30 8C (a marker
that only penetrates cells with severe lesions of the membrane); 0.5 mM FUN-1/106 cells for 30 min at
30 8C (a fluorescent probe which after entering the yeast cell is converted, by metabolically active yeasts, from
a diffuse cytosolic pool with a yellow-green fluorescence into red cylindrical intravacuolar structures) and
0.25 mM of JC-1/106 cells for 15 min at 37 8C (a monomer that changes reversibly from green to red
the J-aggregates, with the increased membrane potential). About 50 000 yeast cells were analysed by
flow cytometry (FCM), at FL3 (red, 620 nm) for PI and FL2 (yellow–green, 575 nm) for FUN-1 and
the ratio of FL3 to FL1 was determined (red, 620 nm/green, 525 nm) for JC-1; 200 cells of each suspension
were also analysed by epifluorescence microscopy (EPM). Viability studies were performed in parallel
to count the number of colony forming units.
Results Susceptible (S) strains exposed to Am B and stained with JC-1 showed a dose-dependent decrease in
the mitochondrial potential, i.e. a decreased ratio between red/green fluorescence by FCM and a decrease in
J-aggregates by EPM. Neither FUN-1 nor PI was useful in the study of Am B activity. Susceptibility to Flu
and 5-FC could be detected with FUN-1 staining: metabolic changes were detected by an increase in
yellow–green intensity of fluorescence by FCM or a decrease of cylindrical intravacuolar structure
formation by EPM, although no decrease in total viability was registered. Staining with JC-1 could predict
resistance to both drugs, but did not allow distinction between sensitive dose-dependent strains (S-DD) or
intermediate (I) resistance to Flu or 5-FC, respectively, from S strains. PI did not stain Candida cells
treated with Flu or 5-FC under our experimental conditions.
Conclusion Susceptibility patterns of Candida strains to Am B can be determined by using JC-1, and to Flu and
5-FC by using FUN-1. PI was not a useful probe with which to study the effect of such antifungals under the
conditions described here.
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INTRODUCTION
The increasing incidence of opportunistic severe fungal infec-
tions has greatly enhanced the interest in novel methods for in
vitro antifungal susceptibility testing. The standardised meth-
odology recommended by the National Committee for Clinical
Laboratory Standards (NCCLS) M27-A [1], represents a sig-
nificant step in the development of a reproducible reference
testing method. Nevertheless this macrodilution technique is
cumbersome and labor intensive. Additionally, its correlation
with the clinical outcome is still under evaluation [2]. During
the last two decades, flow cytometry (FCM) has proved to be a
powerful research tool, e.g. to study the effect of various
compounds on microbes [3–6]. Fluorescent dyes have been
used to study drug–cell interactions [7–9]. Measurement of
alterations in fungal cell viability can be performed with great
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precision using various fluorescent probes which have specific
cellular affinities [10]. Using different probes it is possible to
appreciate pre-lethal changes, either from a metabolic or a
morphological point of view, which may predict the suscept-
ibility pattern to antifungal drugs.
The choice of an ideal probe, and of the optimal experi-
mental conditions for its use, is mainly conditioned by the
biochemical properties of the antifungal drugs.
In this study three different probes were used. Propidium
iodide (PI) is a probe often used to stain non-viable cells. Dead
or dying cells with injured membranes can incorporate PI [11]
which stains the nucleic acids [12]. The second probe, FUN-1
[2-choro-4-(2,3-dihydro-3-methyl-(benzo-1,3-thiazol-2-yl)-
methylidene)-1 phenylquinolinium iodide], was recently devel-
oped by Molecular Probes (Leiden, the Netherlands) as an
indicator of yeast cell viability. Viable cells loaded with
FUN-1 process and concentrate it within their vacuoles,
thereby generating red cylindrical intravacuolar structures
(CIVS) [13]; in non-viable cells, FUN-1 stays in the cytosol
showing a diffuse yellow–green fluorescence and no CIVS. JC-
1 (5,50, 6,60-tetrachloro-1,10,3,30-tetraethylbenzimidazolcarbo-
cyanine iodide), which is a fluorescent probe able to enter
selectively the mitochondria in a monomeric form, emits a
green fluorescence [14,15]. The colour changes from green to
red, forming the J-aggregates, as the mitochondrial membrane
becomes more polarised [16].
Our objective was to define the ideal fluorescent probes and
the conditions for their use in susceptibility testing of Candida
spp. to the three most important antifungal agents, using
cytometric methods.
MATERIALS AND METHODS
Yeast strains
The Candida strains used are listed in Table 1. All the yeasts were
clinical isolates, identified to species level using API 32C
(BioMe´rieux, Vercieux, France). The strains were kept frozen
in Brain–Heart Broth (Difco Laboratories, Detroit, MI, USA)
with 5% glycerol at 70 8C until testing. For each experiment,
the yeasts were subcultured twice on Sabouraud agar (Difco) to
assess the purity of the culture and its viability.
To render the cells non-viable, treatment with 70% ethanol
for 10 min was used.
Antifungal drugs
Amphotericin B (Am B) (Sigma, St Louis, MO, USA), fluco-
nazole (Flu) (Pfizer, Groton, CT, USA) and 5-fluorocytosine
Table 1 Candida strains studied and MIC values (mg/mL) to amphotericin B (AM-B), fluconazole (Flu) and 5-fluorocytosine (5-FC) determined by NCCLS
protocol (M27-A)
Strains Isolates from
MICAmBa
(M27-A)
MICFlua
(M27-A)
Phenotype
Flu
MIC 5-FCa
(M27-A)
Phenotypea
5-FC
C. albicans SCO vaginal 0.5 1 S 0.5 S
C. albicansHV18 bronchial wash 0.25 1 S 1 S
C. albicansHV22 bronchial wash 0.25 16 S-DD 4 S
C. albicansM44 vaginal 0.5 32 S-DD 16 I
C. glabrataHV94 stool 0.25 >64 R 16 I
C. glabrataHV91 bronchial wash 0.5 1 S 1 S
C. kruseiH9 blood 0.25 64 R >64 R
C. kruseiHV10 blood 0.5 >64 R 16 I
C. tropicalisHV28 mouth 16 8 S 1 S
C. lusitaneaH22 mouth 16 0.25 S 0.5 S
C. albicansH65 blood 0.5 >64 R 0.5 S
C. albicansH37 bronchial wash 0.5 >64 R 1 S
C. glabrataH36 blood 0.25 4 S 1 S
C. glabrataH30 blood 0.5 >64 R >64 R
C. lusitaneaH50 urine 0.5 1 S 1 S
C. kruseiH11 blood 1 >64 R >64 R
C. parapsilosisH5 urine 0.5 4 S 4 S
C. parapsilosisH6 blood 1 >64 R >64 R
C. tropicalisH18 blood 0.5 4 S 1 S
C. tropicalisH25 urine 2 4 S 2 S
C. tropicalis13803 ATCC 0.5 4 S 1 S
C. albicans 90028 ATCC 0.5 0.5 S 1 S
C. krusei 6258 ATCC 0.5 64 R 8 I
Classification of the strains according to the same protocol in susceptible (S), resistant (R), susceptible dose-dependent (S-DD) and intermediate (I).
amg/L.
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(5-FC) (Sigma) were prepared as recommended by the NCCLS
protocol M27-A [1], and frozen until use.
Determination of theminimum inhibitory concentration
The minimum inhibitory concentration (MIC) of the assayed
antifungals for each isolate was determined according to the
NCCLS protocol M27-A microdilution method [1], after 48 h
of incubation.
Incubationwith the antifungal drugs
Yeast cells were cultured at 35 8C in Sabouraud broth until late
log phase (as determined by a growth curve constructed from
absorbance readings at OD¼ 600 nm), with shaking
(200 r.p.m.). The cells were centrifuged, suspended in phos-
phate-buffered saline (PBS) (Sigma) supplemented with 2%
glucose, pH¼ 7.0, and counted in a Neubauer chamber.
Suspensions containing 106 cells/mL were incubated with
the antifungal drugs for 1, 2 and 4 h at 35 8C, with shaking
(200 r.p.m.). Two concentrations of each drug (around the
corresponding MIC breakpoints) were used: Amp B, 2 and
8 mg/L; Flu, 8 and 64 mg/L; 5-FCM, 4 and 32 mg/L.
Optimisation of stainingmethods for flow cytometry and
epifluorescencemicroscopy assays
Cell counts
Suspensions with 103107 cells/mL, counted in a Neubauer
chamber, were tested. After this, a suspension of 106 cells/mL
was always used for cytometric studies.
Propidium iodide
Suspensions of untreated cells were incubated for 30 min in the
presence of 1.0, 2.5, 5.0 and 10.0 mg PI (Sigma)/106 cells, in
HEPES solution, pH¼ 7.2, supplemented with 2% glucose
(GH solution), in the dark, at room temperature. Yeast cells
killed by 20 min in 70% ethanol were used as a control for the
staining, after two previous washings with HEPES solution.
Using 1 mg/L PI, we also studied suspensions of ethanol-
exposed cells, stained for up to 180 min
FUN-1
Suspensions of 106 viable cells/mL in GH solution were
incubated in the presence of 0.1–10.0 mM of FUN-1 [2-
choro-4-(2,3-dihydro-3-methyl-(benzo-1,3-thiazol-2-yl)-
methylidene)-1 phenylquinolinium iodide] (Molecular Probes,
Leiden, the Netherlands). Using 0.5 mM FUN-1/106 cells/mL,
we evaluated the variation of staining time up to 180 min.
Viable Candida cells were also incubated for 1 h with 1 mM
sodium azide (Sigma), an inhibitor of yeast metabolism, as a
control for FUN-1 staining [13,17].
JC-1
Viable yeast cells were incubated with JC-1 (5,50, 6,60-tetra-
chloro-1,10,3,30-tetraethylbenzimidazolcarbocyanine iodide)
(Molecular Probes), at concentrations ranging from 0.1 to
5.0 mM/106 cells/mL for 15 min, at 35 8C, in PBS supplemented
with 2% glucose. A kinetic study of the staining was performed
using 0. 25 mM of JC-1/106 cells/mL, with exposure times up to
60 min Yeast cells were also incubated for 1 h with 100 mM of
valinomycin (Sigma) (a Kþ ionophore known to reduce
mitochondrial membrane potential) [15] and washed twice
with PBS previous to staining with JC-1, as a control for the
staining.
Viability assessment
The number of viable cells, both in treated and untreated
suspensions, was determined by counting the number of colony
forming units (CFU)/mL on Sabouraud agar plates, plated with
100 mL serial dilutions. Also, the assessment of the toxicity of the
fluorochrome staining (1 mg/L of PI for 30 min, 0.5 and 1 mM of
FUN-1 for 30 min and 0.25 mM of JC-1 for 15 min) was
evaluated by CFU counts.
Staining protocol for yeast cells treated with antifungals
After treatment with the antifungals, as described above, yeast
cell suspensions were washed to avoid quenching of fluores-
cence [18] and stained with 1 mg PI/106 cells for 30 min at room
temperature, 0.5 or 1 mM of FUN-1/106 cells, or with 0.25 mM
of JC-1/106 cells for 15 min at 37 8C. All the incubations were
carried out in the dark.
A kinetic FCM study of PI and FUN-1 loading (up to
30 min) was performed with Am B-treated cells, i.e. a con-
tinuous measurement of the intensity of fluorescence with
time.
Flow cytometry
The cell suspensions were analysed in a Beckman Coulter XL-
MCL flow-cytometer with an argon 15 mV Laser, after an
optimisation protocol. The cell scattergram [forward scatter
(FS) and side scatter (SS)], the autofluorescence (without
fluorocrome) and the intensity of fluorescence at FL1 (green
fluorescence, 525 nm), at FL2 (yellow–green fluorescence,
575 nm) and at FL3 (red fluorescence, 620 nm) were recorded
using a logarithmic scale. The results are expressed as follows:
for PI, as a percentage of cells showing high fluorescence at FL3;
for FUN-1, a staining index (SI), defined as the ratio between
the mean fluorescence of treated cell suspensions and the
corresponding value for the control (viable) cells at FL2; for
JC-1, a ratio between the mean values of fluorescence at FL3
and FL1, calculated for each antifungal treated-suspension
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and compared with the corresponding value for the untreated
cells.
Each assay was run in duplicate.
Epifluorescencemicroscopy (EPM)
The yeast suspensions were observed under an epifluorescence
microscope (Laborlux K, Leica, Germany) fitted with a mer-
cury 50-W lamp, a BP 450–490 nm excitation filter and an LP
515-nm emission filter. Aliquots of each suspension were placed
between slide and cover slip, after mixing with an anti-fading
reagent (20 mL of the suspensionþ 20 mL of anti-fading reagent)
(Vector Laboratories, Burlingane, CA, USA). For PI we looked
for diffuse red staining of the cells; with FUN-1 the percent-
age of cells showing intravacuolar structures (CIVS) was
determined; and with JC-1 we looked for the presence of
J-aggregates.
Fluorimetry
GH solutions with FUN-1 (0.5 mM) or PI (1 mg/mL), either
with or without Am B (8 mg/L) were analysed by fluorimetry
(Spectrofluorometer FP-770 Jasco).
RESULTS
MIC corresponding to the different antifungals, for the strains
tested strains are shown in Table 1. According to the inter-
pretation guidelines for in vitro susceptibility testing of Candida
isolates [1], the strains were classified as: susceptible (S) to Flu
and 5-FC whenever MIC values were 8 mg/L and 4 mg/L,
respectively; susceptible-dose dependent (S-DD) to Flu when-
ever MIC values were between 16 and 32 mg/L; intermediate
to 5-FC, when MIC values were between 8 and 16 mg/L; and
resistant (R) whenever MIC were 64 mg/L for Flu and
32 mg/L for 5-FC. No breakpoints are yet defined for Am
B. Twenty-one strains showed a low MIC value and two strains
showed a high MIC value (Candida tropicalis HV28 and Candida
lusitanea H22) to Am B (see Table 1).
CFU counts showed that treatment with Am B for 1 h was
highly fungicidal for the strains with low MIC, being con-
siderably less active upon strains with higher MIC values.
Conversely, Flu and 5-FC treatment showed a very minor
effect upon cell viability for all the strains (Table 2 shows
CFU counts for each susceptibility pattern to the different
antifungals). Treatment with ethanol and valinomycin rendered
most cells non-viable (Table 2). However, sodium azide, at
1 mM concentration, did not affect the viability of most of
the cells (Table 2).
A concentration of 106 Candida cells/mL proved to be the
most adequate for flow cytometry assays. The time required to
obtain a representative scatter diagram was too long when using
Table 2 Values of colony formingunits (CFU)/mL for three strains represen-
tative of each pattern of susceptibility to the different antifungals, after
1-hour treatment. H9 was susceptible to amphotericin B (AMB) and resis-
tant to fluconazole (Flu) and 5-fluorocytosine (5-FC); HV28 was a strain
with high MIC toAm B and susceptible to Flu and 5-FC; M44 was a strain
susceptible dose-dependent to Flu and intermediate to 5-FC.The CFU after
exposure to valinomycin (valino), ethanol 70% and sodium azide 1mM are
also represented
H9 M44 HV28
Viable cells 100% 100% 100%
valino100mM 6.3% 5.4% 3.4%
ethanol 70% 0.0% 0.0% 0.0%
azide1mM 90.4% 91.4% 89.2%
AmB 2mg/L 0.0% ^ 84.9%
AmB 8mg/L 0.0% ^ 38.4%
Flu 8mg/L 96.4% 93.6% 125.2%
Flu 64mg/L 94.7% 82.3% 122.5%
5-FC 4mg/L 98.9% 84.4% 120.3%
5-FC 32mg/L 94.6% 112.2% 118.3%
Figure 1 (a) Flow cytometry of Candida albicans SCO cells stained with
propidium iodide (PI) and analysed at FL3 (620nm) showing: (trace a)
autofluorescence of untreated (viable) cells; (trace b) autofluorescence of
ethanol-treated (dead) cells; (trace c) fluorescence of untreated (viable) cells
stained with 1mg/L of PI for 30min; and (trace d) fluorescence of ethanol-
treated (dead) cells stained with 1mg/L of PI for 30min. (b) Kinetics of the
stainingof ethanol-treated (dead) cells ofCandida albicansSCOwith1mg/L
of propidium iodide during180min.
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lower cell concentrations, i. e. 103105 cells/mL; thus 180 min
were needed to analyse 8000 cells (data not shown). Conversely,
when assaying 107 cells/mL, the yeasts showed a marked
tendency to aggregate and interrupt the liquid flow through
the detector unit.
The results with PI indicate that 1 mg/106 cells is the optimal
concentration for this fluorescent probe; stained viable cells
show a fluorescence level similar to that of the autofluorescence
and a clear distinction between viable and ethanol-killed cells is
achieved (Figure 1a and Table 3). The intensity of PI staining
(under the above mentioned conditions) of Candida cells killed
by 10 min in 70% ethanol, increased during the initial 30 min,
the intensity of the staining remaining constant afterwards
(Figure 1b). Cells treated with ethanol showed a high perme-
ability to the dye (i.e. >90% of cells stained) and were found to
be dead by CFU counting.
As a concentration of 0.5mM FUN-1/106 cells still provided
good staining properties, it was chosen for further flow cyto-
metry testing (Figure 2a,b). An increase in the intensity of
fluorescence was evident when analysing cells exposed to
sodium azide (Figure 2b). With the above indicated fluoro-
chrome concentration, viable cells showed a quick increase in
fluorescence during the first minutes, being maximum at
30 min, which was immediately followed by a slight decrease
(Figure 2c). After 30 min, FUN-1 staining stabilised, at least
during the following 3 h (Figure 2c). However, for EPM,
cells treated with FUN-1 at 1 mM/106 cells/mL showed
bigger cylindrical orange-red fluorescent CIVS, making the
observation easier. CIVS were evident only in viable cells;
conversely, an extremely bright diffuse yellow-green fluores-
cence was present in azide-exposed cells (not shown),
under EPM.
Table 3 Values of intensity of fluorescence at FL3 (620nm) determined by
flow cytometry with increased concentrations of propidium iodide (PI) for
30min
PI (mg/L) Viablea (FL3) Deadb (FL3)
0 0.252 0.344
1.0 0.297 43.700
2.5 0.450 43.100
5.0 0.569 46.900
10.0 0.810 89.400
aViable cells indicates non-treated cells; bdead cells indicates ethanol-
treated cells.
Figure 2 (a) Intensity of fluorescence of untreated (viable) cells ofCandida albicans SCOafter staining with different concentrations of FUN-1for 30min. (b)
Flow cytometry of Candida albicans SCO cells stained with FUN-1and analysed at FL2 (575nm) showing: (trace a) autofluorescence of untreated (viable)
cells; (trace b) fluorescence of untreated (viable) cells stained with 0.5mM of FUN-1for 30min; and (trace c) fluorescence of yeast cells treated with 1mM of
sodium azide and stainedwith 0.5mMof FUN-1for 30min. (c) Kinetics of the staining of untreated (viable) cells ofCandida albicansSCOwith 0.5mMof FUN-1
for180min.
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With JC-1, 0.25 mM/106 cells/mL was the minimum con-
centration that could stain the yeast cells (Figure 3a), with
15 min being the optimal incubation time (Figure 3b). The
exposure of yeast cells to valinomycin resulted in a decrease in
the mean intensity of the ratio of FL3 to FL1, in comparison
with untreated, viable cells (Table 4). EPM analysis showed
two or three red aggregates per untreated yeast cell, the
J-aggregates, which were not present after incubation with
valinomycin.
After treatment with Am B the yeast cells of the different
strains showed a slight decrease in the forward light
scatter, indicating a slight decrease in size. Although more
than 99% of cells of strains with a low MIC value to Am B
were dead, neither PI nor FUN-1 was able to stain them.
Conversely, such cells showed less intensity of staining by FCM
than untreated yeasts (Figure 4). Under EPM, no cells were
stained by PI nor did any show CIVS. Thus, a reduced loading
of PI and FUN-1 was seen in both FCM and EPM in Am B-
treated cells. The reduction in staining did not result from
interference of the antifungal with the dyes, as deduced from
the observation that the spectrophotometric spectra of both
probes were not altered by the presence of Am B (data not
shown).
With JC-1, a decrease in the mean value of FL3 : FL1 was
seen only on strains with low MIC values (see strain H9 as a
representative example on Table 4) and the J-aggregates were
not present under EPM.
After Flu and 5-FC treatment PI did not enter the cells in any
of the strains tested. However FUN-1 staining allowed a clear
distinction between the S and the R strains to both drugs
(Figures 5 and 6). S strains to Flu and 5-FC showed an increase
in the mean intensity of fluorescence at FL2 (see strain HV28 as
a representative strain on Figures 5 and 6), with a corresponding
decrease in the number of cells with CIVS (not shown), despite
the cells being able to grow (Table 2). R strains showed a
staining index by FC similar to viable cells (SI> 1) (see strain
H9 as a representative strain on Figures 5 and 6). Correspond-
ingly, under EPM more than 95% of cells showed CIVS, which
is in accordance with the viability testing (Table 2). S-DD strains
to Flu and I strains to 5-FC presented a SI< 1 with the lower
concentrations tested; however, a SI> 1 was seen with the
highest drug concentration (Flu 64 mg/L or 5-FC 32 mg/L)
(see strain M44 as a representative strain on Figures 5
and 6).
Strains classified as either S, S-DD, or I to Flu and 5-FC,
respectively, and stained with JC-1 showed a decrease in the
mean value of FL3 : FL1, compared to untreated cells (see a
representative strain in Table 4). Thus no distinction between
such susceptibility patterns was possible. With R strains no
decrease in the ratio FL3 : FL1 was detected (see strain H9 as a
representative on Table 4).
One hour was found to be an adequate incubation period,
the results with longer incubation times (2 and 4 h) being similar
(not shown).
Figure 3 (a) Intensity of fluorescence of FL3 (620 nm): FL1 (525 nm)
of untreated (viable) cells of Candida albicansSCOafter staining with differ-
ent concentrations of JC-1 for 15 min. (b) Kinetics of the staining of
untreated (viable) cells of Candida albicans SCO with 0.25mM of JC-1 for
15min.
Table 4 Values of the ratio between the intensity of fluorescence at FL3
(625nm) andFL1 (525nm)determinedby flowcytometry of untreatedcells
(viable cells) and after 1h treatment with valinomycin (valino), amphotericin
B (AMB), fluconazole (Flu) and 5-fluorocytosine (5-FC)after staining with
JC-1. The three strains represented a typical susceptibility pattern to each
antifungal: H9 was susceptible to Am B and resistant to Flu and 5-FC;
HV28 was a strain with a high MIC value to Am B and susceptible to Flu
and 5-FC; M44 was a strain susceptible dose-dependent to Flu, and inter-
mediate to 5-FC
H9 M44 HV28
Viable cells 1.289 1.339 1.287
Valino100mM 0.507 0.623 0.611
Am B 2mg/L 0.484 ^ 1.346
Am B 8mg/L 0.700 ^ 1.353
Flu 8mg/L 1.497 0.534 0.584
Flu 64mg/L 1.607 0.447 0.559
5-FC 4mg/L 2.019 0.544 0.469
5-FC 32mg/L 1.788 0.445 0.401
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Figure 5 Flowcytometryof the strainCandida
kruseiH9(anexample of a resistant strain to Flu
and Candida tropicalis HV28 (an example of a
susceptible strain to Flu) and Candida glabrata
M44 (anexample of a susceptible-dosedepen-
dent strain to Flu) after treatment with 0, 8 and
64mg/Lof Flu (0,8 and 64on the figure) for1h
and stainedwith propidium iodide (PI) or FUN-
1. The autofluorescence (af) of the cells is also
represented.
Figure 4 Flow cytometry of strain Candida
kruseiH9 (an example of a strain with lowMIC
value toAmB) andCandida tropicalisHV28 (an
example of a strain with high MIC value to Am
B) after treatment with 0 and 8mg/L of Am B
(0 and 8 on the figure) for 1h and stained with
propidium iodide (PI) or FUN-1. The autofluor-
escence (af) of the cells is also represented.
 2001 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 7, 609–618
Pina-Vaz et al Cytometric evaluation of Candida susceptibility 615
DISCUSSION
In this paper three probes were optimised for use in suscept-
ibility testing to three of the most widely used antifungals. FCM
was shown to be a good alternative for the study of metabolic or
functional alterations in yeast cells. EPM was an excellent tool to
help in cytometric interpretation. However, no single probe
was useful to study all three drugs. PI is one of the most popular
fluorescent probes used in susceptibility testing by cytometric
methods [5,19]. However, we found it to be inadequate to
evaluate the susceptibility to the tested antifungals. This may be
explained by the need for significant damage to the cell
membrane to take place to allow the access of PI to the target.
According to our previous studies Candida cells exposed to
drugs that are fungicidal by direct membrane damage, such as
ibuprofen [20], benzydamine and local anesthetics [21], incor-
porated PI in a dose-dependent manner. Also, the activity of
echinocandin B could be studied with PI, after 3-h treatment
Figure 6 Flow cytometry of the strain Candida kruseiH9 (an example of a strain that is resistant to 5-FC) andCandida tropicalisHV28 (an example of a strain
susceptible for 5-FC) and Candida albicansM44 (an example of an intermediate strain to 5-FC) after treatment with 0.4 and 32mg/L of 5-FC (0, 4 and 32 on
the figure) for1h and stained with propidium iodide (PI) or FUN-1.The autofluorescence (af) of the cells is also represented.
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[22]. Although Am B is a fungicidal drug, inducing Kþ leakage
[23], it is a large molecule that acts on the yeast cytoplasmic
membrane in a way that probably interferes with the uptake of
most molecules. Thus, the uptake of PI by Am B-treated cells,
compared to untreated cells, is significantly reduced, as the cells
become increasingly more impermeable in the presence of Am
B. Ramani et al. [19] was able to increase red fluorescence with
PI staining on Am B- and Flu-treated cells, but only after
association with a membrane detergent (sodium deoxycolate).
Am B-treated cells also remained impermeable to FUN-1,
with less staining by FCM than untreated cells, and showing no
CIVS under EPM. According to other reports, in yeast cells
treated with Am B for 3 h, 4 additional hours were needed for
penetration of ethidium bromide into the membrane [18]. A
decrease in the uptake of DIOC5 (another fluorescent probe)
with increasing concentrations of Am B was also described
[24,25]. We used JC-1 to study the susceptibility of yeasts to Am
B for the first time. It allowed us to study the effect of Am B,
probably due to its lipophilic properties which facilitate the
crossing of the membrane and the staining of the yeast cells.
The decreased forward-angle light scatter seen on Am
B-treated cells reflects minor morphological changes (decrease
in size), already described [18].
Azoles are fungistatic drugs, with no effect on yeast cell
viability. Accordingly, we found that after 1-h treatment with
Flu, PI could not enter the cell. FUN-1 is an interesting marker
with which to study yeast metabolism, which has previously
been used to study functional changes induced by acetic acid on
yeasts [17]. We found it to be extremely useful to distinguish S
(SI> 1) from S-DD (SI< 1 with Flu 8mg/L and SI> 1 with
Flu 64 mg/L) and R strains (SI< 1) to Flu. The decrease in SI by
FCM and the corresponding observation under EPM that a
large number of cells had CIVS in R strains could be explained
by the presence of efflux pumps [26, 27], which are a frequent
mechanism of resistance to azoles [27]. Thus, the fluorescent
probe might be exported from the yeast cell, together with the
antifungal.
Treatment with 5-FC for 1 h did not kill the cells, as
determined by CFU counts (see on Table 2) and was unable
to make the cells permeable to PI, in accordance with Pore [5]
(Figure 6). However, a significant metabolic disturbance was
detected with FUN-1 staining, as both S and I strains showed a
dose-dependent increase of fluorescence at FL2 (Figure 6) and a
decrease in the percentage of cells with CIVS (not shown).
Our results show that JC-1 can also be useful to detect
resistance to Flu and to 5-FC, although it was not sensitive
enough, under the assayed conditions, to distinguish between
S-DD (Flu) or I (5-FC) and S patterns.
According to our data, susceptibility to Am B could be
detected after 1 h of exposure to the antifungal and staining
with JC-1, susceptibility being correlated with the absence
of J-aggregates and a decrease in mean value of FL3 : FL1
fluorescence. Susceptibility to Flu and 5-FC could be deter-
mined after incubation with the drugs for 1 h followed by
staining with FUN-1. A SI> 1 indicates that the strain is S and a
SI< 1 that it is R, having an excellent correlation with the MIC
results.
In conclusion, our results demonstrate an excellent correla-
tion between the results of cytometric methods and the classic
susceptibility methods for the assayed antifungals. Cytometry
allows a significant time-saving in antifungal susceptibility
testing compared to classical protocols. This is of particular
interest and importance when reliable and accurate answers are
needed in the shortest possible time, as is the case in immu-
nocompromised patients, like such as those with leukemia and
bone marrow recipients, in whom we cannot afford the chance
of mistakes.
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